Postes actifs de Frank P. Holladay
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TVAX BIOM | Directeur Technique/Scientifique/R&D | 14/07/2011 | - |
| Fondateur | 14/07/2011 | - | |
| TVAX Biomedical I LLC | Directeur Technique/Scientifique/R&D | 01/11/2004 | - |
| Fondateur | 01/11/2004 | - |
Historique de carrière de Frank P. Holladay
Formation de Frank P. Holladay
| University of California, Berkeley | Undergraduate Degree |
| Creighton University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
| TVAX Biomedical I LLC |
- Bourse
- Insiders
- Frank P. Holladay
- Expérience
